Guest Episode
Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program (ITP)
Ep. #281 with Richard Miller M.D., Ph.D.
AMA
Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent
Ep. #246 (AMA #45)
Guest Episode
The biology of aging, rapamycin, and other interventions that target the aging process
Ep. #175 with Matt Kaeberlein, Ph.D.
Free Article
Funding geroscience; suggested podcast listening
Free Article
How long can we live?; suggested listening
Guest Episode
The gold standard for testing longevity drugs: the Interventions Testing Program
Ep. #148 with Richard Miller, M.D., Ph.D.
Free Article
A few things worth sharing: 10-04-2020
Guest Episode
Rapamycin and metformin—longevity, immune enhancement, and COVID-19
Ep. #123 with Joan Mannick, M.D. & Nir Barzilai, M.D.
Guest Episode
Rapamycin, mTOR inhibition, and the biology of aging
Ep. #118 with Lloyd Klickstein M.D., Ph.D.
Guest Episode
Autophagy, fasting, and promising new cancer therapies
Ep. #114 with Eileen White, Ph.D.
Guest Episode
How cellular senescence influences aging, and what we can do about it
Ep. #112 with Ned David, Ph.D.
